Radionuclide therapy using I-131-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression
文献类型:期刊论文
| 作者 | Li, W; Liu, ZY ; Li, CX; Li, N ; Fang, L; Chang, J; Tan, J
|
| 刊名 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
![]() |
| 出版日期 | 2016-03-01 |
| 卷号 | 142期号:3页码:619-632 |
| 关键词 | Epidermal growth factor receptor Nanoparticles I-131 Radioiodine therapy Tumor-targeting |
| ISSN号 | 0171-5216 |
| 产权排序 | [Li, Wei; Li, Chengxia; Li, Ning; Tan, Jian] Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Anshan Rd 154, Tianjin 300052, Peoples R China; [Liu, Zhongyun] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai 264003, Shandong, Peoples R China; [Fang, Lei; Chang, Jin] Tianjin Univ, Inst Nanobiotechnol, Sch Mat Sci & Engn, Tianjin Key Lab Composites & Funct Mat, Tianjin 300072, Peoples R China |
| 通讯作者 | Tan, J (reprint author), Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Anshan Rd 154, Tianjin 300052, Peoples R China. tanpost@163.com |
| 英文摘要 | Introduction Anti-epidermal growth factor receptor (EGFR)-targeted nanoparticles can be used to deliver a therapeutic and imaging agent to EGFR-overexpressing tumor cells. I-131-labeled anti-EGFR nanoparticles derived from cetuximab were used as a tumor-targeting vehicle in radionuclide therapy. |
| 研究领域[WOS] | Oncology |
| 关键词[WOS] | EFFICIENT DRUG-DELIVERY ; BREAST-CANCER ; IN-VITRO ; ANTICANCER DRUGS ; TUMOR-THERAPY ; NUDE-MICE ; LIPOSOMES ; EXPRESSION ; RELEASE ; RADIOTHERAPY |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000370173600009 |
| 源URL | [http://ir.yic.ac.cn/handle/133337/10863] ![]() |
| 专题 | 烟台海岸带研究所_山东省海岸带环境工程技术研究中心 烟台海岸带研究所_海岸带生物学与生物资源利用所重点实验室 |
| 作者单位 | 1.Tianjin Med Univ, Gen Hosp, Dept Nucl Med 2.Chinese Acad Sci, Yantai Inst Coastal Zone Res 3.Tianjin Univ, Inst Nanobiotechnol, Sch Mat Sci & Engn, Tianjin Key Lab Composites & Funct Mat |
| 推荐引用方式 GB/T 7714 | Li, W,Liu, ZY,Li, CX,et al. Radionuclide therapy using I-131-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,2016,142(3):619-632. |
| APA | Li, W.,Liu, ZY.,Li, CX.,Li, N.,Fang, L.,...&Tan, J.(2016).Radionuclide therapy using I-131-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,142(3),619-632. |
| MLA | Li, W,et al."Radionuclide therapy using I-131-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression".JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 142.3(2016):619-632. |
入库方式: OAI收割
来源:烟台海岸带研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


